Sign in
4/A

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-138836

Chief Financial Officer sold 20,000 shares at $8.00 ($160,000)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2016-08-22 Exercise or conversion : show line 1 in the form +13,100 $2.01 $26,331 128,789 D
2016-08-22 Sale : show line 2 in the form −13,100 $8.00 $104,800 115,689 D
2016-08-23 Exercise or conversion : show line 3 in the form +6,900 $2.01 $13,869 122,589 D
2016-08-23 Sale : show line 4 in the form −6,900 $8.00 $55,200 115,689 D
Open-market sales · 20,000 sh · avg $8.00 · $160,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2016-08-22 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −13,100 348,900 D
2016-08-23 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −6,900 342,000 D
Loading xslF345X03/doc4a.xml…